We analyzed the expression level of S1P receptors, i.e., S1PR1, S1PR2, S1PR3, S1PR4, and S1PR5 [27], in the TCGA-GTEx GBM patient cohort. This evidence concerns the gene S1PR2 and glioblastoma.